Gallant, Joel E <br/><br/>
Antiviral Activity, Safety, and Pharmacokinetics of Bictegravir as 10-Day Monotherapy in HIV-1-Infected Adults.  [electronic resource] 

 -  Journal of acquired immune deficiency syndromes (1999)  05 2017 
 - 61-66 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1944-7884 
<br/><br/><label>Standard No.: </label>10.1097/QAI.0000000000001306  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Amides<br/>Double-Blind Method<br/>Drug-Related Side Effects and Adverse Reactions--epidemiology<br/>Female<br/>HIV Infections--drug therapy<br/>HIV Integrase Inhibitors--administration & dosage<br/>HIV-1--drug effects<br/>Heterocyclic Compounds, 3-Ring<br/>Heterocyclic Compounds, 4 or More Rings--administration & dosage<br/>Humans<br/>Male<br/>Middle Aged<br/>Piperazines<br/>Placebos--administration & dosage<br/>Plasma--chemistry<br/>Pyridones<br/>RNA, Viral--blood<br/>Treatment Outcome<br/>Viral Load<br/>Young Adult